CCO Independent Conference Coverage

2006 Annual San Antonio Breast Cancer Symposium*

December 14-17, 2006 | San Antonio, Texas

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Early Breast Cancer: Endocrine Therapy

Track 1 of 4

Faculty:

Nancy E. Davidson, MDPeter Ravdin, MD, PhDChristy Russell, MD
  • Nancy E. Davidson, MD
  • Peter Ravdin, MD, PhD
  • Christy Russell, MD

Early Breast Cancer: Chemotherapy and Targeted Agents

Track 2 of 4

Faculty:

Edith A. Perez, MDNicholas J. Robert, MDJoseph A. Sparano, MD
  • Edith A. Perez, MD
  • Nicholas J. Robert, MD
  • Joseph A. Sparano, MD

Metastatic Breast Cancer

Track 3 of 4

Faculty:

Clifford A. Hudis, MDGeorge W. Sledge, Jr., MDDebu Tripathy, MD
  • Clifford A. Hudis, MD
  • George W. Sledge, Jr., MD
  • Debu Tripathy, MD

Detection, Diagnosis, Screening, and Prevention

Track 4 of 4

Faculty:

William J. Gradishar, MD, FACPDaniel F. Hayes, MDHope S. Rugo, MD
  • William J. Gradishar, MD, FACP
  • Daniel F. Hayes, MD
  • Hope S. Rugo, MD

Expert Highlights

Peter Ravdin, MD, PhD headshot

Peter Ravdin, MD, PhD, discusses endocrine therapy strategies in the adjuvant setting. (4.5 minutes)

Download Audio
Nicholas J. Robert, MD headshot

Nicholas J. Robert, MD, highlights clinical trial data and vaccine therapy in early stage breast cancer. (5 minutes)

Download Audio
Clifford A. Hudis, MD headshot

Clifford A. Hudis, MD, discusses emerging targeted therapies in the treatment of metastatic breast cancer. (6 minutes)

Download Audio
Hope S. Rugo, MD headshot

Hope S. Rugo, MD, reviews detection, prevention, and risk stratification data. (2.5 minutes)

Download Audio

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.